Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema

Caramat, İsmail; Isik, Ridvan; eyigor, sibel; Yesil, Hilal

Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema

HİLAL YEŞİL, (Department of Physical Medicine and Rehabilitation, Medical Faculty of Afyon Kocatepe University, Afyon, Turkey)

Sibel EYİGÖR, (Department of Physical Medicine and Rehabilitation, Medical Faculty of Afyon Kocatepe University, Afyon, Turkey)

İsmail CARAMAT, (Department of Physical Medicine and Rehabilitation, Medical Faculty of Ege University, İzmir, Turkey)

Rıdvan IŞIK (Department of Physical Medicine and Rehabilitation, Medical Faculty of Ege University, İzmir, Turkey)

Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi

1 0

Yıl: 2017 Cilt: 63 Sayı: 4 Sayfa Aralığı: 329 - 334 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema

Öz:

Objectives: To investigate the effects of complex decongestive therapy (CDT) on the quality of life, depression, neuropathic pain, and fatigue in patients with breast cancer-related lymphedema (BCRL).Patients and methods: Between March 2015 and June 2015, a total number of 60 patients (mean age 55.7±10.3 years; range 18 to 85 years) with BCRL were included in the study. Demographic data and previous medical records were recruited from medical files. The European Organization for Research and Treatment of Cancer Quality of Life- C30 (EORTC QLQ-C30) for the quality of life, the Brief Fatigue Inventory (BFI) for fatigue, Douleur Neuropathique 4 Questions (DN4) for neuropathic pain, and the Beck Depression Inventory (BDI) for the emotional status were used before and after the treatment. All patients received 20 sessions (one hour) of CDT for four weeks (five days per week).Results: There was a statistically significant reduction in the volume of the involved limbs after the treatment (p<0.001). There was also a significant reduction in the general health and functional scores of the EORTC QLQ-C30 (p<0.001, p=0.004, respectively). The DN4, BFI, and BDI scores were significantly improved after the treatment (p<0.001, p=0.043, p=0.019, respectively).Conclusion: Our study results suggest that CDT is an effective and safe method to achieve not only a significant volume reduction in the limbs involved by lymphedema, but also good outcomes in the management of other symptoms related to BCRL.

Anahtar Kelime:

Konular: Rehabilitasyon

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Lyon: International Agency for Research on Cancer; 2014. Available from: http://globocan.iarc.fr [Accessed: January 16, 2015]
2. Eyigor S, Kanyilmaz S. Exercise in patients coping with breast cancer: An overview. World J Clin Oncol 2014;5:406-11.
3. Salonen P, Rantanen A, Kellokumpu-Lehtinen PL, Huhtala H, Kaunonen M. The quality of life and social support in significant others of patients with breast cancer--a longitudinal study. Eur J Cancer Care (Engl) 2014;23:274-83.
4. Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R 2012;4:580-601.
5. McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer 2005;104:457-66.
6. Smoot B, Wong J, Cooper B, Wanek L, Topp K, Byl N, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv 2010;4:167-78.
7. Schmitz KH, Ahmed RL, Troxel AB, Cheville A, LewisGrant L, Smith R, et al. Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 2010;304:2699-705.
8. Pinto M, Gimigliano F, Tatangelo F, Megna M, Izzo F, Gimigliano R, et al. Upper limb function and quality of life in breast cancer related lymphedema: a cross-sectional study. Eur J Phys Rehabil Med 2013;49:665-73.
9. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009;27:2007-14.
10. Mayrovitz HN. The standard of care for lymphedema: current concepts and physiological considerations. Lymphat Res Biol 2009;7:101-8.
11. Forner-Cordero I, Muñoz-Langa J, Forner-Cordero A, DeMiguel-Jimeno JM. Predictive factors of response to decongestive therapy in patients with breast-cancer-related lymphedema. Ann Surg Oncol 2010;17:744-51.
12. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a qualityof-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76.
13. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999;85:1186-96.
14. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29-36.
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
16. Taghian NR, Miller CL, Jammallo LS, O'Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol 2014;92:227-34.
17. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol 2008;26:5689-96.
18. Noh S, Hwang JH, Yoon TH, Chang HJ, Chu IH, Kim JH. Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients. Ann Rehabil Med 2015;39:347-59.
19. Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, et al. NCCN Practice Guidelines for CancerRelated Fatigue. Oncology (Williston Park) 2000;14:151-61.
20. Fu MR, Rosedale M. Breast cancer survivors' experiences of lymphedema-related symptoms. J Pain Symptom Manage 2009;38:849-59.
21. Gurdal SO, Kostanoglu A, Cavdar I, Ozbas A, Cabioglu N, Ozcinar B, et al. Comparison of intermittent pneumatic compression with manual lymphatic drainage for treatment of breast cancer-related lymphedema. Lymphat Res Biol 2012;10:129-35.
22. Alcorso J, Sherman KA. Factors associated with psychological distress in women with breast cancer-related lymphoedema. Psychooncology 2016;25:865-72.
23. Atalay OT, Özkir A, Çalik BB, Baskan E, Taşkin H. Effects of phase I complex decongestive physiotherapy on physical functions and depression levels in breast cancer related lymph edema. J Phys Ther Sci 2015;27:865-70.
24. Fu MR, Axelrod D, Cleland CM. Symptom report in detecting breast cancer-related lymphedema. Breast Cancer (Dove Med Press) 2015;7:345-52.
25. Fu MR. Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol 2014;5:241-7.
26. Hidding JT, Beurskens CH, van der Wees PJ, van Laarhoven HW, Nijhuis-van der Sanden MW. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One 2014;9:e96748.
27. Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol 2007;18:639-46.
28. Hamner JB, Fleming MD. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol 2007;14:1904-8.

APA	Yesil H, eyigor s, Caramat İ, Isik R (2017). Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. , 329 - 334.
Chicago	Yesil Hilal,eyigor sibel,Caramat İsmail,Isik Ridvan Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. (2017): 329 - 334.
MLA	Yesil Hilal,eyigor sibel,Caramat İsmail,Isik Ridvan Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. , 2017, ss.329 - 334.
AMA	Yesil H,eyigor s,Caramat İ,Isik R Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. . 2017; 329 - 334.
Vancouver	Yesil H,eyigor s,Caramat İ,Isik R Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. . 2017; 329 - 334.
IEEE	Yesil H,eyigor s,Caramat İ,Isik R "Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema." , ss.329 - 334, 2017.
ISNAD	Yesil, Hilal vd. "Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema". (2017), 329-334.

APA	Yesil H, eyigor s, Caramat İ, Isik R (2017). Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 63(4), 329 - 334.
Chicago	Yesil Hilal,eyigor sibel,Caramat İsmail,Isik Ridvan Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 63, no.4 (2017): 329 - 334.
MLA	Yesil Hilal,eyigor sibel,Caramat İsmail,Isik Ridvan Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, vol.63, no.4, 2017, ss.329 - 334.
AMA	Yesil H,eyigor s,Caramat İ,Isik R Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2017; 63(4): 329 - 334.
Vancouver	Yesil H,eyigor s,Caramat İ,Isik R Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2017; 63(4): 329 - 334.
IEEE	Yesil H,eyigor s,Caramat İ,Isik R "Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema." Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 63, ss.329 - 334, 2017.
ISNAD	Yesil, Hilal vd. "Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema". Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 63/4 (2017), 329-334.